Caricamento...

Long‐term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2‐year study

OBJECTIVE: To evaluate the long‐term clinical and exercise effect of chronic oral administration of the non‐selective endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension (PAH) related to congenital heart disease (CHD). DESIGN: Extension of a preceding prospective...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Apostolopoulou, S C, Manginas, A, Cokkinos, D V, Rammos, S
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2007
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1861451/
https://ncbi.nlm.nih.gov/pubmed/16980516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.100388
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !